An explanation for different results may be represented by the small study group of AML cases and controls investigated by Rybka et al. A previous study suggested that TLR9 rs187084 influenced the outcome of transplants in AML cases after a myeloablative, non-T-cell-depleted transplant. The gene discussed is TLR9; the disease is acute myeloid leukemia.